ABEMACICLIB

Clinical trials for ABEMACICLIB explained in plain language.

Never miss a new study

Get alerted when new ABEMACICLIB trials appear

Sign up with your email to follow new studies for ABEMACICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3

New drug combo aims to stop breast Cancer's second strike

Disease control Recruiting now

This study is for people whose hormone-positive, HER2-negative breast cancer has returned in the breast or nearby lymph nodes after initial treatment. It tests if adding a drug called abemaciclib to standard hormone therapy is better at preventing the cancer from coming back or s…

Matched conditions: ABEMACICLIB

Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

ABEMACICLIB

Get alerted when new ABEMACICLIB trials appear

New drug combo aims to stop breast Cancer's second strike